Decheng Capital China Life Sciences Usd Fund Iii, L.p. - Net Worth and Insider Trading

Decheng Capital China Life Sciences Usd Fund Iii, L.p. Net Worth

The estimated net worth of Decheng Capital China Life Sciences Usd Fund Iii, L.p. is at least $306 Million dollars as of 2024-11-13. Decheng Capital China Life Sciences Usd Fund Iii, L.p. is the 10% Owner of Alpine Immune Sciences Inc and owns about 4,708,288 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $306 Million. Details can be seen in Decheng Capital China Life Sciences Usd Fund Iii, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Decheng Capital China Life Sciences Usd Fund Iii, L.p. has not made any transactions after 2021-09-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Decheng Capital China Life Sciences Usd Fund Iii, L.p.

To

Decheng Capital China Life Sciences Usd Fund Iii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Decheng Capital China Life Sciences Usd Fund Iii, L.p. owns 2 companies in total, including Alpine Immune Sciences Inc (ALPN) , and Cue Health Inc (HLTHQ) .

Click here to see the complete history of Decheng Capital China Life Sciences Usd Fund Iii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Decheng Capital China Life Sciences Usd Fund Iii, L.p.

Ticker Comapny Transaction Date Type of Owner
ALPN Alpine Immune Sciences Inc 2021-09-17 10 percent owner
HLTHQ Cue Health Inc 2021-09-23 10 percent owner

Decheng Capital China Life Sciences Usd Fund Iii, L.p. Latest Holdings Summary

Decheng Capital China Life Sciences Usd Fund Iii, L.p. currently owns a total of 1 stock. Decheng Capital China Life Sciences Usd Fund Iii, L.p. owns 4,708,288 shares of Alpine Immune Sciences Inc (ALPN) as of September 17, 2021, with a value of $306 Million.

Latest Holdings of Decheng Capital China Life Sciences Usd Fund Iii, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALPN Alpine Immune Sciences Inc 2021-09-17 4,708,288 64.97 305,897,471

Holding Weightings of Decheng Capital China Life Sciences Usd Fund Iii, L.p.


Decheng Capital China Life Sciences Usd Fund Iii, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Decheng Capital China Life Sciences Usd Fund Iii, L.p. has made a total of 1 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Alpine Immune Sciences Inc is the acquisition of 1,542,553 shares on September 17, 2021, which cost Decheng Capital China Life Sciences Usd Fund Iii, L.p. around $15 Million.

Insider Trading History of Decheng Capital China Life Sciences Usd Fund Iii, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Decheng Capital China Life Sciences Usd Fund Iii, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Decheng Capital China Life Sciences Usd Fund Iii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Decheng Capital China Life Sciences Usd Fund Iii, L.p. is 36.2%. GuruFocus also compares Decheng Capital China Life Sciences Usd Fund Iii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Decheng Capital China Life Sciences Usd Fund Iii, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Decheng Capital China Life Sciences Usd Fund Iii, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Decheng Capital China Life Sciences Usd Fund Iii, L.p.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.8 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 12.93 LIMIT LIMIT LIMIT LIMIT LIMIT

Decheng Capital China Life Sciences Usd Fund Iii, L.p. Ownership Network

Ownership Network List of Decheng Capital China Life Sciences Usd Fund Iii, L.p.

No Data

Ownership Network Relation of Decheng Capital China Life Sciences Usd Fund Iii, L.p.

Insider Network Chart

Decheng Capital China Life Sciences Usd Fund Iii, L.p. Owned Company Details

What does Alpine Immune Sciences Inc do?

Who are the key executives at Alpine Immune Sciences Inc?

Decheng Capital China Life Sciences Usd Fund Iii, L.p. is the 10 percent owner of Alpine Immune Sciences Inc. Other key executives at Alpine Immune Sciences Inc include Senior VP and CFO James Paul Rickey , director & Executive Chairman and CEO Mitchell Gold , and director & 10 percent owner Xiangmin Cui .

Alpine Immune Sciences Inc (ALPN) Insider Trades Summary

Over the past 18 months, Decheng Capital China Life Sciences Usd Fund Iii, L.p. made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,587,529 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,529 shares.

Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alpine Immune Sciences Inc Insider Transactions

No Available Data

Decheng Capital China Life Sciences Usd Fund Iii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Decheng Capital China Life Sciences Usd Fund Iii, L.p.. You might contact Decheng Capital China Life Sciences Usd Fund Iii, L.p. via mailing address: Ugland House, Po Box 309, Grand Cayman E9 Ky1-1104.